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Simple 1,3-diamines and their application as
ligands in ruthenium(II) catalysts for asymmetric
transfer hydrogenation of aryl ketones†
Giorgio Facchetti, Raﬀaella Gandolfi, Marco Fuse`, Daniele Zerla, Edoardo Cesarotti,
Michela Pellizzoni and Isabella Rimoldi*
In this research work simple unsymmetrical 1,3-diamines were studied. The synthesis of the diamines started
from non-commercial available compounds. S-5a and S,S-5c were obtained by biocatalysis with non
conventional yeast, Rhodotorula rubra MIM 147, with excellent 99% e.e. and d.e. up to 90%. Diﬀerent
approaches of synthesis were applied to the same backbone to study both the steric and electronic eﬀects
of the ligands. The reactivity of the corresponding ruthenium complexes was evaluated in the asymmetric
hydrogen transfer reduction of acetophenone as a standard substrate and of other diﬀerent aryl ketones,
highlighting the flexibility of the six membered chelating ring. A screening of the reaction conditions indicated
aqueous media in the presence of HCOONa as a hydrogen donor to be the best system for overcoming the
lack of stereocontrol thus allowing us to obtain 56% e.e. in the reduction of acetophenone with the complex
in which the ligand was diamine 1, revealed as the best in terms of reactivity and stereoselectivity also in the
reduction of the other diﬀerent aryl ketones, in particular for a-tetralone, i (63% e.e.).
Introduction
In the last decade asymmetric transfer hydrogenation (ATH)
has been revealed as a valid alternative to the use of molecular
H2 in obtaining enantiomerically pure alcohols which can be
applied to the synthesis of many fine chemicals, pharmaceuticals
and agrochemical products.1
It is well known that the performance of the catalytic system
is strictly related to a synergistic eﬀect between the solvent
nature and the hydrogen donor. In recent years the develop-
ment of ATH in aqueous media has been emerged as a valid
alternative to the use of organic solvents for its non-toxic,
economic and environmental compatible profile.
Since the pioneering work reported by Noyori and Ikariya
groups in 1995,2,3 the catalysts of choice in ATH reductions of
ketones have been established to be the ruthenium(II) complexes
chelating diﬀerent substituted 1,2-diamines such as DPEN and
its derivatives, among them the monotosylated compounds were
revealed as the most eﬃcient ones.3–11
All these types of catalysts were based on the presence of
ligands forming five membered rings when chelated to the
metal centre. Some examples of symmetric 1,4-diamines and few
examples of 1,3-diamines were reported in the literature,12–17mainly
used as a typical ruthenium complex [(diphosphine)-RuCl2-
(diamine)] for hydrogenation of simple aromatic and aliphatic
ketones, in the catalytic addition of diethylzinc to aldehyde or
in the Cu-catalyzed enantioselective Henry reaction.18–21
Considering the wide range of 1,2-diamines used as ligands
and their utility in asymmetric catalysis, this work reported the
synthesis of simple asymmetric monotosylated 1,3-diamines,
up to now poorly investigated in ATH (Fig. 1), and the evaluation
of their catalytic performances.
Results and discussion
The starting material for the synthesis of these 1,3-diamines was
the reduction products of benzoylacetonitrile and its ethylated
derivative.
Diﬀerent approaches using either asymmetric transfer hydro-
genation for the reduction of benzoylacetonitrile 5 with
iridium(III)22 and/or ruthenium(II) diamines complexes23 or
Fig. 1 Monotosylated 1,3-diamines.
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whole-cell catalysts24,25 were studied. Recently our group dis-
played the reduction of the substrate 5 and its corresponding
ethylated derivative 5b using Carreira’s [Cp*Ir(diamine)(H2O)]SO4
complexes in which the diamine ligand CAMPY and its derivatives
were used as a source of chirality26 with good stereoselectivity.
Unfortunately it was not enough to use these products as starting
materials for the synthesis of enantiomerically pure diamines.
Good results were obtained by a biotransformation reaction which
has been studied especially by Gotor and Dehli27–29 employing the
fungus Curvularia lunata. In these studies they underlined the
production of the expected side product, 2-(1-hydroxy-1-phenyl-
methyl)butanenitrile 5c, during the biotransformation occurring
on benzoylacetonitrile 5.
Based on the above results we decided to investigate diﬀer-
ent yeasts capable of reducing the same substrate 5 and its
derivative 5b. A screening of diﬀerent genera and species of
yeasts available in our laboratory’s library was carried out (data
not reported) (Fig. 2).
Most of them resulted to produce ethylated keto-compound
5b as the major product while 3-hydroxy-3-phenylpropanenitrile
5 was produced in a minor amount in the presence of glucose as
a co-substrate.
The group of red to pinkish yeasts is one of themost interesting
biocatalysts30–33 in the reduction of differently substituted aryl-
ketones and among them Sporobolomyces salmonicolor is the best
known for this application. As expected, this yeast was able to
produce the desired product 5a in a quantitative yield with 80%
e.e. in S configuration avoiding the use of any co-substrate. In the
presence of EtOH as a co-substrate this yeast afforded 5a and 5c in
a 50/50 mixture along with a decreasing enantiomeric excess.
Best results were obtained when two similar yeasts were used:
Rhodotorula rubra MIM 146 and Rhodotorula rubra MIM 147. In
both cases 5a was the only product yielded in an excellent 98% e.e.
in S configuration.With the aim of verifying the ability of these two
yeasts to reduce and resolve compound 5b, its racemic mixture
was quantitatively synthesised by Saccharomyces cerevisiae which
mediated non-stereoselective introduction of the ethyl group.34,35
With R. rubra MIM 146 the conversion of racemic 5b in 5c was
achieved in 48 h with 78% d.e. and499% e.e. in S,S configuration.
The best result was obtained with R. rubra MIM 147 which
produced S,S-5c at the same time with 499% e.e. and with a
d.e. up to 90% thus allowing us to completely separate the two
diastereomers using classical chromatographic techniques.
First of all, starting from linear substrate S-5a, two diﬀerent
types of diamines were synthesised in which the tosyl-amine
moiety was set either on the aliphatic chain or on the preformed
stereocentre (Scheme 1).
After obtaining the corresponding aminoalcohol 6a by reduction
with LiAlH4, the synthesis proceeded into two diﬀerent pathways.
The cyclisation with CDI in CH2Cl2 gave the corresponding (S)-6-
phenyl-1,3-oxazinan-2-one 7a with the retention of configuration.36
Successively, the reaction with NaH and TsCl provided 6-phenyl-3-
tosyl-1,3-oxazinan-2-one 10a, with an excellent yield (80% after
crystallization). In the second pathway, after protecting the amino
group with (Boc)2O, substrate 8a reacts with TsCl in the presence of
4-DMAP and TEA directly giving 10a with the inversion of configu-
ration at the chiral centre.
Indeed, under these specific conditions, the formation of TsO-
on the benzylic alcohol and the tosylation of the amido moiety
allowed by the 4-DMAP drove a SN2 reaction. This methodology
appears to be very appealing considering that starting from only
one isomer we obtained both the enantiomers of 10a (Scheme 1).
Fig. 2 Biotransformation of benzoylacetonitrile by yeasts.
Scheme 1 Synthesis of linear diamines 1.
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Substrate 10a, with the strong nucleophile NaN3 in DMF,
underwent SN2 substitution on the chiral centre resulting in
the opening of the cycle and the decarboxylation. The corre-
sponding azides were reduced in the presence of Pd/C to
monotosylated diamines, N-(3-amino-3-phenylpropyl)-4-methyl-
benzenesulfonamides 1. For the synthesis of the analogue
monotosylated diamine 2, we planned a procedure starting
from S-6a. The amino moiety was firstly protected with 1-[2-
(trimethylsilyl)ethoxycarbonyloxy]pyrrolidin-2,5-dione (Teoc-OSu).
Then the classic procedure, by which the alcoholic function was
reacted with mesyl chloride in the presence of TEA,16 was
performed unfortunately giving 9a the corresponding oxazina-
none R-7a, with inversion of configuration, as observed when
Boc is used as a protecting group for the amino moiety. There-
fore, an alternative starting material, (R)-(+)-3-chloro-1-phenyl-
1-propanol, for the synthesis of enantiopure diamine S-2, was
studied. The synthesis proceeded as reported in the following
scheme (Scheme 2).
The second type of diamine was synthesised starting from the
reduced ethylated product 5c. The synthesis of diamine 3 vs. 1
mirrored each other from the beginning to the end (Scheme 3).
In the case of diamine 4, the methodology was the same as
that initially thought for diamine 2 but in this case the formation
of oxazinanone 7c did not take place and after removing the Teoc
protecting group with ZnBr2,
37 diamine 4 was obtained in a
quantitative yield.
The so synthesised diamines were reacted with [Ru( p-
cymene)Cl2]2 to give the corresponding ruthenium(II) complexes
assuming a six membered ring conformation. The synthesis of
the ruthenium(II) complexes here reported was realised by reflux-
ing in toluene for 3 h and utilised without further purification as
a pre-catalyst in ATH. Diﬀerent reaction conditions were evalu-
ated using acetophenone as a test substrate. With regard to
solvents, water was revealed to be the best choice, as when iPrOH
or MeOH was employed, the reaction conversion resulted
significantly decreased.5,38 In the same way the selection of
hydrogen donors39 (HCOOH, HCOONa, azeotropic mixture
5 : 2 = TEA:HCOOH and iPrOH) proved HCOONa among others,
in a ratio of 10 : 1 with the substrate, as the best in terms of the
enantioselectivity achieved. In fact by using a diﬀerent hydro-
gen donor, a racemic mixture of the product was obtained in all
cases. Conversely the temperature variation (20 1C, 40 1C or
60 1C) did not show any significant eﬀect on enantioselectivity.
Results obtained for the four diamine ligands under the set
reaction conditions: water as a solvent and HCOONa as a
hydrogen donor at 40 1C are reported in Table 1.
Unexpectedly the presence of an additional chiral centre in
position 2 of the ligands 3 and 4 did not improve the enantio-
selectivity but in contrast it negatively influenced the stereo-
selectivity of the catalysts along with a significant decrease in the
reaction rate (entries 3 and 4 vs. 1 and 2). The results obtained by
changing the position of the tosyl moiety confirmed the impor-
tance of the stereogenic centre to be in proximity of the amine
involved in the catalytic cycle contributing to increase both
the reaction conversion and enantioselectivity through a steric
and/or an electronic eﬀect (entries 1 vs. 2 and 3 vs. 4).
The reactivity and selectivity of the complexes carrying the
linear diamines 1 and 2 were studied in ATH of diﬀerent aryl
ketones (Table 2).
The best results both in terms of the reaction rate and enantio-
selectivity were achieved with the catalyst bearing diamine ligandScheme 2 Synthesis of linear diamines 2.
Scheme 3 Synthesis of ethylated diamines 3 and 4.
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R-1 when compared to catalyst carrying S-2 diamine (entries 1–9 vs.
10–18). In particular in the reduction of a-tetralone, an appreciable
63% e.e. was achieved with a yield of 70% in 48 h (entry 9).40–42
Conclusions
Easily prepared 1,3-diamines were developed starting from
chiral substrates. The production of the starting material was
realised by a biocatalytic approach using a non-conventional
yeast, Rhodotorula rubra MIM 147, achieving very good results
in terms of stereoselectivity, yield and recovery.
The catalytic data showed that when a six membered ring
was formed by employing 1,3-diamines as a source of chirality,
enlarged when compared to the one obtained by using 1,2
ligands, a lower optical induction was observed due to the
flexibility of the chelating ring as already underlined for
the diphosphine ligands.43 Nevertheless the right combina-
tion between the hydrogen donor and the solvent proved to
drastically influence the catalytic performance of this type of
catalyst as well as the electronic and steric properties of the
substrate.
Experimental section
General
1H and 13C NMR spectra were recorded in CDCl3 or CD3OD on a
Bruker DRX Avance 300 MHz equipped with a non-reverse
probe at 25 1C. Chemical shifts (in ppm) were referenced to
the residual solvent proton/carbon peak. FTIR spectra were
collected by using a Perkin Elmer (MA, USA) FTIR Spectrometer
‘‘Spectrum One’’ in a spectral region between 4000 and 450 cm1
and analysed using the transmittance technique with 32 scans per
ion and 4 cm1 resolution. Polarimetry analyses were carried
out on a Perkin Elmer 343 Plus equipped with a Na/Hal lamp.
ESI-MS analyses were performed by using a Thermo Finnigan
(MA, USA) LCQ Advantage system MS spectrometer with an
electronspray ionisation source and an ‘Ion Trap’ mass analyser.
The MS spectra were obtained by direct infusion of a sample
solution in MeOH under ionisation, ESI positive. Catalytic reac-
tions were monitored by gas chromatography analysis using a
chiral stationary phase column (MEGA DMT b, 25 m, internal
diameter 0.25 mm) or by HPLC analysis with Merck-Hitachi
L-7100 equipped with Detector UV6000LP and chiral column
(OD-H Chiralcel or AD Chiralpak) and with JASCO PU-2080 Plus
(OJ-H Chiralcel). Commercially reagent grade solvents were
dried according to standard procedures and freshly distilled
under nitrogen before use.
Enzymatic synthesis of rac-2-benzoylbutanenitrile 5b
Commercial Baker’s yeast (50 g L1) was suspended in a
phosphate buﬀer (200 mL, 0.1 M, pH 7) containing 50 g L1
of glucose and 5 g L1 of substrate 5. The biotransformation
system was shaken using a mechanic stirrer at 28 1C. When
the total conversion was achieved, the cells were separated by
centrifugation. Both the aqueous phases and the cell mixture
were extracted with diethyl ether (3  50 mL), dried with
Na2SO4 and the solvent was removed in vacuo. The crude
product was purified by flash chromatography (CH2Cl2/hexane/
ethyl acetate = 4 : 1 : 1) to give 860 mg of 5b (86% yield). 1H NMR
(300 MHz, CDCl3): d = 1.16 (t, J = 7.7 Hz, 3H, –CH3), 2.02–2.15
(m, 2H, –CH2–), 4.30 (dd, J = 6.2, 4.3 Hz, 1H, –CH–), 7.49–7.56
(m, 2H, arom), 7.65 (d, J = 7.6 Hz, 1H, arom), 7.95 (d, J = 6.7 Hz,
2H, arom) ppm; 13C NMR (75 MHz, CDCl3): d = 190.88, 170.91,
134.63, 133.93, 130.38, 129.31, 128.92, 128.68, 41.38, 23.77, 11.89
ppm; IR n = 3467, 2975, 2936, 2249, 1694, 1597, 1449, 1265, 1233,
1208, 1000, 696 cm1; elemental analysis for C11H11NO: C, 76.28;
H, 6.40; N, 8.09; found: C, 76.13; H, 6.34; N, 7.98; MS (ESI) of
C11H11NO m/z 196.1 ([M + Na]
+).
Table 1 ATH of acetophenone using [Ru(p-cymene)(L)Cl] complexes
Entry Liganda Conversionb (%) e.e.b (%)
1 R-1 97 56 (S)
2 S-2 68 33 (R)
3 S,R-3 44 22 (R)
4 R,S-4 18 4 (R)
a Reactions were carried out at 40 1C using 0.5 mmol of the substrate
with 0.5 mol% of the ruthenium complex in 3 mL of water in the
presence of 10 equiv. HCOONa as a hydrogen donor. b Conversion was
determined by NMR and e.e. was determined by HPLC after 48 h.
Table 2 ATH of diﬀerent aryl ketones
Entrya Ligand Substrate Conversionb (%) e.e.b (%)
1 R-1 a 40 0
2 b 70 41 (S)
3 c 95 40 (S)
4 d 46 18 (S)
5 e 43 23 (S)
6 f 50 35 (S)
7 g — —
8 h — —
9 i 70 63 (S)
10 S-2 a 5 0
11 b 15 34 (R)
12 c 35 24 (R)
13 d 8 15 (R)
14 e — —
15 f 15 5 (R)
16 g — —
17 h — —
18 i 10 0
a Reactions were carried out at 40 1C using 0.5 mmol of the substrate
with 0.5 mol% of the ruthenium complex in 3 mL of water in the
presence of 10 equiv. HCOONa as a hydrogen donor. b Conversion was
determined by NMR and e.e. was determined by HPLC after 48 h.
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General procedure of biotransformation with Rhodotorula
rubra MIM 147
Rhodotorula rubra MIM 147 was routinely maintained on malt
extract slants (8 g L1, yeast extract 5 g L1, agar 15 g L1, pH 5.6).
The strain, grown on malt extract slants for 72 h at 28 1C, was
inoculated into 1000 mL Erlenmeyer flasks containing 150 mL of
the same liquid medium and incubated on a reciprocal shaker
(100 spm) for 48 h at 28 1C. Cells obtained by centrifugation
(4000 g for 15 min at 4 1C) of the culture broth (1 L) were washed
with deionised water (3 200 mL). After lyophilisation 20 g L1 of
yeast was suspended in 500 mL of 0.1 M phosphate buﬀer pH = 7
containing 50 g L1 of glucose. The substrates dissolved in DMSO
were added to the biotransformation system in 2 g L1 (5) or
1 g L1 (rac-5b) of substrate concentration and 1% of the solvent.
The biotransformation system was shaken using a mechanic
stirrer at 28 1C for 48 h. The cells were separated by centrifugation
and broth were extracted with diethyl ether (3  150 mL), dried
with Na2SO4 and the solvent was removed in vacuo. The crude
product was purified by flash chromatography (ethyl acetate/
cyclohexane = 7 : 3) to give 786 mg of S-5a (78% yield) or 287 mg
of S,S-5c (57% yield).
S-5a. All characterization data are in agreement with the
previously reported literature.22,23,44,45 [a]20D = 63.8 (c = 1,
CHCl3); HPLC data: HPLC data for 5a: OJ-H Chiralcel, eluent:
hexane : 2-propanol = 90 : 10, flow = 1.0 mL min1, l = 216 nm;
rt: (S) = 24.5 min, (R) = 30.8 min.
S,S-5c. 1H NMR (CDCl3, 300 MHz): d = 1.09 (t, J = 7.7 Hz, 3H,
–CH3), 1.51–1.69 (m, 2H, –CH2–), 2.76–2.83 (m, 1H, –CH–), 4.79
(d, J = 6.2 Hz, 1H, –CH–), 7.33–7.56 (m, 5H) ppm; 13C NMR
(CDCl3, 75 MHz): d = 140.71, 128.69, 128.05, 127.04, 76.57,
24.85, 10.38 ppm; IR n = 3390, 2964, 1494, 1453, 160, 1103,
1038, 702 cm1; elemental analysis for C11H13NO: C, 75.40; H,
7.48; N, 7.99; found: C, 75.23; H, 7.32; N, 7.89; MS (ESI) of
C11H13NO m/z 198.3 ([M + Na]
+). [a]20D = 46.4 (c = 0.5, CHCl3).
HPLC data: Chiralcel OD-H, eluent: hexane : 2-propanol = 95 : 5,
flow = 0.8 mL min1, l = 216 nm; rt: (R,S) = 26.9 min, (S,S) =
28.6 min, (S,R) = 34.2 min, (R,R) = 36.4 min.
General synthesis of aminoalcohol 6a or S,S-6c
To a solution of 5a or S,S-5c (1.72mmol) in anhydrous THF (10mL),
LiAlH4 was added (100mg, 2.6mmol) and the resultingmixture was
stirred under a nitrogen atmosphere at 0 1C. After 1 hour, some
water was carefully added in order to quench the excess LiAlH4 and
the solution was then reduced in volume and extracted with
dichloromethane (3  15 mL). The organic layers were dried on
Na2SO4, filtered and evaporated to give the product.
(S)-3-Ammino-1-phenylpropan-1-ol S-6a. Pale yellow oil
(200 mg, 77% yield). [a]20D = 44.38 (c = 0.3, CHCl3); 1H NMR
(300 MHz, CDCl3): d = 1.78–1.82 (m, 2H, –CH2–), 2.48–2.52 (br,
2H, NH2) 2.95–2.98 (m, 2H, –CH2–), 4.92 (dd, J = 4.03, 8.06 Hz,
1H, –CH–), 7.21–7.38 (m, 5H, arom) ppm; 13C NMR (75 MHz,
CDCl3): d = 145.16, 128.43, 128.14, 127.20, 125.85, 125.54, 75.44,
40.57, 39.87 ppm; IR n = 3360, 2917, 2874, 1601, 1492, 1453,
1337, 1062 cm1; MS (ESI) of C9H13NO m/z 152.0 ([M + H]
+),
174.1 ([M + Na]+).
(1S,2S)-2-(Aminomethyl)-1-phenylbutan-1-ol S,S-6c. Yellow
oil (215 mg, 84% yield). [a]20D = 18.3 (c = 2.0, CHCl3);
1H NMR (300 MHz, CDCl3): d = 0.88 (m, 3H, –CH3); 1.26–1.30
(m, 2H, –CH2–); 2.87–2.91 (m, 2H, –CH2–); 2.95–2.97 (m, 1H,
–CH–); 3.09 (br, 2H, NH2); 4.71(d, J = 6.59 Hz, 1H, –CH–); 5.2
(s, 1H, OH); 7.23–7.38 (m, 5H, arom) ppm; 13C NMR (75 MHz,
CDCl3): d = 145.05, 128.31, 128.07, 127.14, 126.73, 126.55, 79.45,
47.11, 43.42, 22.36, 11.79 ppm; IR n = 3367, 3305, 2960, 2929,
2874, 1601, 1493, 1453, 1043, 1026, 701 cm1; MS (ESI) of
C11H17NO m/z 180.1 ([M + H]
+).
General synthesis of oxazinanones 7a or S,S-7c
N,N0-Carbonyldiimidazole (204 mg, 1.35 mmol) was added to a
solution of 6a or S,S-6c in CH2Cl2 at room temperature and the
resulting mixture was stirred for 12 h. Then, the solvent was
evaporated and the residue solved in ethylacetate and washed
with aqueous HCl (0.1 M) and water. After drying and elimina-
tion of the solvent, crystallization by diﬀusion of hexane into
the acetone solution aﬀorded the product.
(S)-6-Phenyl-1,3-oxazinan-2-one S-7a. White solid (179 mg,
75% yield). [a]20D = 37.4 (c = 0.7, CHCl3); 1H NMR (300 MHz,
CDCl3): d = 2.14–2.17 (m, 2H, –CH2–), 3.39–2.44 (m, 2H, –CH2–),
5.34 (dd, J = 2.93, 9.53 Hz, 1H, –CH–), 5.81 (s, 1H, NH), 7.26–
7.39 (m, 5H, arom) ppm; 13C NMR (75 MHz, CDCl3): d = 154.61,
138.67, 128.85, 128.59, 125.85, 78.83, 39.17, 28.91 ppm; IR
n = 3389, 2966, 2878, 1797, 1682, 1494, 1456, 800, 702 cm1;
elemental analysis for C10H11NO2: C, 67.78; H, 6.26; N, 7.90;
found: C, 67.68; H, 6.24; N, 7.88; MS (ESI) of C10H11NO2 m/z
200.1 ([M + Na]+).
(5S,6S)-5-Ethyl-6-phenyl-1,3-oxazinan-2-one S,S-7c. White
solid (177 mg, 72% yield). [a]20D = 7.0 (c = 0.7, CHCl3); 1H NMR
(300 MHz, CDCl3): d = 0.84 (t, J = 7.33 Hz, 3H, –CH3), 1.21–1.25
(m, 2H, –CH2–), 2.02–2.05 (m, 1H, –CH–), 3.12 (t, J = 9.89 Hz, 1H,
–CHH–), 3.43–3.49 (m, 1H, –CHH–), 4.97 (d, J = 8.79 Hz, 1H, –CH–),
5.27 (s, 1H, NH), 7.29–7.36 (m, 5H, arom) ppm; 13C NMR (75 MHz,
CDCl3): d = 155.38, 138.14, 128.86, 128.75, 128.55, 127.15, 126.05,
84.04, 43.81, 38.79, 22.31, 11.09 ppm; IR n = 3435, 2961, 2925,
2854, 1698, 1457, 1355, 802, 761 cm1; elemental analysis for
C12H15NO2: C, 70.22; H, 7.37; N, 6.82; found: C, 70.13; H, 7.33;
N, 6.79; MS (ESI) of C12H15NO2 m/z 206.1 ([M + H]
+).
General synthesis of tosyl-oxazinanones S-10a or S,S-9c
To a solution of S-7a or S,S-7c (1.69 mmol) in anhydrous THF at
0 1C the stoichiometric amount of NaH was added (68 mg,
1.69 mmol). After thirty minutes the solution of tosyl chloride
in THF (387 mg, 2.03 mmol) was dropped into the former
solution and stirred at room temperature overnight. The resulting
solution was quenched with water and extracted with trichloro-
methane (3  10 mL). The collected organic layers were dried
on Na2SO4, filtered and evaporated to give a yellow oil then
purified by crystallization in dichloromethane–hexane to pro-
vide the product.
(S)-6-Phenyl-3-tosyl-1,3-oxazinan-2-one S-10a. White solid
(440 mg, 80% yield). [a]20D = 24.7 (c = 0.5, CHCl3); 1H NMR
(300 MHz, CDCl3): d = 2.25–2.29 (m, 2H, –CH2–), 2.45 (s, 3H, –CH3),
4.00–4.08 (m, 2H, –CH2–), 5.34 (dd, J = 2.93, 9.53 Hz, 1H, –CH–),
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7.23–7.37 (m, 7H, arom), 7.94 (d, J = 8.43 Hz, 2H, arom) ppm;
13C NMR (75 MHz, CDCl3): d = 148.82, 145.44, 137.61, 135.37,
129.68, 129.16, 129.06, 129.03, 125.75, 79.67, 44.22, 29.89, 21.93
ppm; IR n = 3436, 2976, 2923, 1709, 1354, 1174, 1148 cm1;
elemental analysis for C17H17NO4S: C, 61.62; H, 5.17; N, 4.23;
found: C, 61.57; H, 5.13; N, 4.20; MS (ESI) of C17H17NO4S m/z
354.1 ([M + Na]+).
(5S,6S)-5-Ethyl-6-phenyl-3-tosyl-1,3-oxazinan-2-one S,S-9c.White
solid (351 mg, 58% yield). [a]20D = 5.8 (c = 0.6, CHCl3); 1H NMR
(300 MHz, CDCl3): d = 0.85–0.89 (m, 3H, –CH3), 1.31–1.35 (m, 2H,
–CH2–), 2.05–2.12 (m, 1H, –CH–), 2.46 (s, 3H, –CH3), 3.65 (dd, J =
2.19, 9.53 Hz, 1H, –CHH–), 4.11 (dd, J = 5.13, 6.59 Hz, 1H, –CHH–),
4.96 (d, J = 8.43 Hz, 1H, –CH–), 7.19–7.43 (m, 7H, arom), 7.91–7.97
(m, 2H, arom) ppm; 13C NMR (75 MHz, CDCl3): d = 148.89, 145.33,
136.82, 135.52, 129.66, 129.28, 129.12, 128.97, 126.89, 84.63, 48.41,
40.31, 22.39, 21.85, 11.06 ppm; IR n = 3426, 2964, 2882, 2101, 1719,
1353, 1175, 1158, 885, 700 cm1; elemental analysis for
C19H21NO4S: C, 63.49; H, 5.89; N, 3.90; found: C, 63.52; H,
5.93; N, 3.94; MS (ESI) of C19H21NO4S m/z 360.2 ([M + H]
+).
Synthesis of (R)-6-phenyl-3-tosyl-1,3-oxazinan-2-one R-10a
To a solution of 8a (270 mg, 1.08 mmol) in fresh-distilled
dichloromethane, 4-dimethylaminopyridine (99mg, 0.81mmol)
and triethylamine (2 mL, 14.04 mmol) were added. The reaction
mixture was then cooled to 10 1C and stirred for half an hour.
A solution of tosyl chloride (267 mg, 1.4 mmol) in dichloro-
methane was then dropped into the former solution and stirred
overnight allowing the reaction mixture to reach room tempera-
ture. The reaction was monitored by TLC using dichloromethane/
diethyl ether 1 : 1 as an eluent. After 24 h the reaction is com-
pleted. The desired product was obtained as a white solid by slow
diﬀusion of hexane into the acetone solution (152 mg, 43% yield).
[a]20D = +24.7 (c = 0.25, CHCl3). All characterization data are in
agreement with that previously reported for S-10a.
General synthesis of azido benzenesulfonamides 11a or S,R-10c
To a solution of 10a or S,S-9c in anhydrous DMF (0.30 mmol),
NaN3 was added (98.2 mg, 1.51 mmol). The solution was refluxed
at 120 1C for 3.5 h under a N2 atmosphere. After cooling to room
temperature, water was added and the solution was extracted with
diethyl ether (3  10 mL). The collected organic layers were dried
on Na2SO4, filtered and evaporated to give the product.
(R)-N-(3-Azido-3-phenylpropyl)-4-methylbenzenesulfonamide
R-11a. Orange oil (49 mg, 50% yield). [a]20D = +61.2 (c = 0.5,
CHCl3);
1H NMR (300 MHz, CDCl3): d = 1.86–1.90 (m, 2H, –CH2–),
2.42 (s, 3H, –CH3), 3.00–3.05 (m, 2H, –CH2–), 4.52 (t, J = 7.33 Hz,
1H, –CH–), 5.16 (t, J = 7.12 Hz, 1H, NH) 7.19–7.37 (m, 7H, arom)
7.73 (d, J = 8.43 Hz, 2H, arom) ppm; 13C NMR (75MHz, CDCl3): d =
143.79, 138.96, 137.02, 130.01, 129.15, 128.74, 127.34, 127.03,
63.78, 40.47, 36.24, 21.73 ppm; IR n = 3283, 3063, 3032, 2927,
2876, 2099, 1663, 1598, 1454, 1326, 1160, 1093, 909, 815 cm1; MS
(ESI) of C16H18N4O2S m/z 353.2 ([M + Na]
+).
S)-N-(3-Azido-3-phenylpropyl)-4-methylbenzenesulfonamide
S-11a. Orange oil (50 mg, 51% yield). [a]20D = 75.0 (c = 0.25,
CHCl3). All characterization data are in agreement with that
previously reported for R-11a.
N-((S)-2-((R)-Azido(phenyl)methyl)butyl)-4-methylbenzene-
sulfonamide S,R-10c. Pale yellow oil (73 mg, 68% yield). [a]20D =
+103.5 (c = 0.4, CHCl3);
1H NMR (300 MHz, CDCl3): d = 0.81–
0.86 (m, 3H, –CH3), 1.24–1.29 (m, 2H, –CH2–), 1.73–1.79 (m, 1H,
–CH–), 2.44 (s, 3H, –CH3), 2.89 (t, J = 6.23 Hz, 2H, –CH2–), 4.59–
4.63 (m, 2H, –CH– + NH), 7.13–7.36 (m, 7H, arom), 7.69
(d, J = 6.59 Hz, 2H, arom) ppm; 13C NMR (75 MHz, CDCl3):
d = 146.76, 138.25, 136.95, 131.09, 130.71, 130.55, 130.40, 128.32,
86.06, 49.84, 41.75, 23.82, 21.43, 12.49 ppm; IR n = 3282, 2964,
2933, 2101, 1711, 1666, 1328, 1160, 1093, 911 cm1; MS (ESI) of
C18H22N4O2S m/z 359.3 ([M + H]
+).
General synthesis of amino benzensulfonamides R-1, S-1 or S,R-3
In a stainless steel autoclave (20 mL), equipped with tempera-
ture control and a magnetic stirrer, purged five times with
hydrogen, a solution of 11a or S,R-10c (0.15 mmol) in methanol
with 1% of Pd/C was transferred. The autoclave was pressurised
at 20 atm and kept under stirring at room temperature for four
hours. The mixture was then filtered on Celite and the solvent
was evaporated in vacuo to give the product.
(R)-N-(3-Amino-3-phenylpropyl)-4-methylbenzenesulfonamide
R-1. Yellow oil, without any further purification step (43 mg,
95% yield). [a]20D = +8.0 (c = 0.4, CHCl3);
1H NMR (300 MHz,
CDCl3): d = 1.89 (dd, J = 5.87, 12.09 Hz, 2H, –CH2–), 2.42 (s, 3H,
–CH3), 2.91–2.95 (m, 2H, –CH2–), 4.04 (t, J = 5.87 Hz, 1H, –CH–),
4.25–4.54 (br, 2H, NH2), 7.17–7.29 (m, 7H, arom), 7.72 (d, J =
8.07 Hz, 2H, arom) ppm; 13C NMR (75 MHz, CDCl3): d = 143.10,
142.74, 136.82, 129.60, 128.73, 127.64, 127.05, 126.29, 54.34,
40.71, 36.43, 21.42 ppm; IR n = 3350, 3293, 2917, 2099, 1650,
1598, 1454, 1323, 1156, 1094, 951, 815 cm1; MS (ESI) of
C16H20N2O2S m/z 305.2 ([M + H]
+).
(S)-N-(3-Amino-3-phenylpropyl)-4-methylbenzenesulfonamide
S-1. Pale yellow oil (45 mg, quantitative yield). [a]20D = 7.6
(c = 0.24, CHCl3). All characterization data are in agreement
with that previously reported for R-1.
N-((S)-2-((R)-Amino(phenyl)methyl)butyl)-4-methylbenzene-
sulfonamide S,R-3. White solid (44.3 mg, 89% yield). [a]20D = +4
(c = 0.3, CH3OH);
1H NMR (300 MHz, CD3OD): d = 0.85–0.87 (m,
3H, –CH3), 1.19–1.22 (m, 2H, –CH2–), 1.73–1.76 (m, 1H, –CH–),
2.45 (s, 3H, –CH3), 2.86–2.91 (m, 2H, –CH2–), 4.15 (d, J = 3.29 Hz,
1H, –CH–), 7.05–7.33 (m, 7H, arom), 7.75 (d, J = 8.06 Hz, 2H,
arom) ppm; 13C NMR (75 MHz, CD3OD): d = 143.51, 140.92,
136.64, 129.53, 128.54, 127.68, 126.96, 55.94, 45.51, 42.45, 20.27,
19.18, 9.75 ppm; IR n = 3436, 3292, 2963, 2925, 1631, 1320, 1151,
1093, 803, 704 cm1; elemental analysis for C18H24N2O2S: C,
65.03; H, 7.28; N, 8.43; found: C, 64.97; H, 7.23; N, 8.39; MS
(ESI) of C18H24N2O2S m/z 333.0 ([M + H]
+).
Synthesis of tert-butyl-(S)-(3-hydroxy-3-phenylpropyl)
carbamate S-8a
To a solution of 6a (520 mg, 2.94 mmol) in a mixture of THF/
water 1 : 1, Na2CO3 was added (720 mg, 6.76 mmol). The
solution was then cooled to 0 1C and a solution of di-tert-
butyl dicarbonate (770 mg, 3.53 mmol) in 5 mL THF was added
dropwise. After 1 h stirring at 0 1C, the solution was warmed to
room temperature and stirred for further 3 h. The reaction was
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monitored by TLC using dichloromethane/diethyl ether 1 : 1 as
an eluent. After 4 h the reaction was complete and water was
added to the mixture and extracted with diethyl ether (3 10 mL)
to give the product as a yellow oil (575 mg, 78% yield). [a]20D =
18.9 (c = 0.4, CHCl3); 1H NMR (300 MHz, CDCl3): d = 1.41 (s, 9H,
–C(CH3)3), 1.75–1.79 (m, 2H, –CH2–), 3.16–3.20 (m, 1H, –CHH–),
3.37–3.63 (m, 2H, –CHH– + OH), 4.64 (m, 1H, –CH–), 5.23 (br,
1H, NH), 7.25–7.31 (m, 5H, arom) ppm; 13C NMR (75 MHz, CDCl3):
d = 157.05, 144.54, 128.65, 127.59, 125.87, 79.76, 71.95, 39.77, 37.83,
28.63 ppm; IR n = 3363, 3274, 2975, 1677, 1546, 1291, 1180, 1025,
981 cm1; MS (ESI) of C14H21NO3 m/z 274.10 ([M + Na]
+).
General synthesis of Teoc-amino alcohols S-9a or S,S-8c
The synthesis proceeded according to methodology reported in
the literature.46
2-(Trimethylsilyl)ethyl (S)-(3-hydroxy-3-phenylpropyl)carbamate
S-9a. Colourless oil (405 mg, 93% yield). [a]20D = 12.3 (c = 1.5,
CHCl3);
1H NMR (300 MHz, CDCl3): d = 0.02 (s, 9H, –C(CH3)3), 0.89
(t, J = 8.43 Hz, 2H, –CH2–), 1.75 (q, J = 6.6 Hz, 2H, –CH2–), 3.11–3.27
(m, 2H, –CH2–), 4.05 (t, J = 8.43 Hz, 2H, –CH2–), 4.60–4.66 (q, J =
5.50 Hz, 1H, –CH–), 5.42 (br, 1H, NH), 7.14–7.26 (m, 5H, arom)
ppm; 13C NMR (75MHz, CDCl3): d = 169.19, 157.58, 144.78, 128.60,
127.67, 127.43, 125.98, 125.88, 71.97, 70.66, 63.14, 39.32, 25.60,
17.95,1.27 ppm; IR n = 3403, 2953, 1743, 1694, 1525, 1251, 1062,
860, 838 cm1; MS (ESI) of C15H25NO3Si m/z 318.2 ([M + Na]
+).
2-(Trimethylsilyl)ethyl ((S)-2-((S)-hydroxy(phenyl)methyl) butyl)-
carbamate S,S-8c. White oil (374 mg, 82% yield). [a]20D = 9.5 (c =
0.5, CHCl3);
1H NMR (300 MHz, CDCl3): d = 0.09 (s, 9H, –C(CH3)3),
0.93 (t, J = 4.03 Hz, 3H, –CH3), 0.97–1.02 (m, 2H, –CH2–), 1.17–1.28
(m, 2H, –CH2–), 1.69–1.75 (m, 1H, –CH–), 3.18–3.25 (m, 1H,
–CHH–), 3.49–3.63 (m, 1H, –CHH–), 4.15 (t, J = 9.16 Hz, 2H,
–CH2–), 4.48 (d, J = 7.7 Hz, 1H, –CH–), 5.10 (br, 1H, NH), 7.24–
7.34 (m, 5H, arom) ppm; 13C NMR (75 MHz, CDCl3): d = 157.93,
143.54, 129.25, 128.60, 127.79, 126.77, 74.23, 63.44, 63.39,
47.73, 41.74, 21.61, 19.16, 17.99, 12.13, 1.24 ppm; IR n = 3391,
2958, 1694, 1519, 1251, 1064, 1041, 860, 837 cm1; MS (ESI) of
C17H29NO3Si m/z 346.3 ([M + Na]
+).
Synthesis of (R)-6-phenyl-1,3-oxazinan-2-one R-7a
A solution of S-9a (405 mg, 1.37 mmol) and triethylamine (380 mL,
2.74 mmol) in anhydrous THF (10 ml) was cooled to 0 1C. Mesyl
chloride (130 mL, 1.64 mmol) in THF (2 mL) was added dropwise.
The reaction was stirred for 2 h, filtrated and the solvent evapo-
rated in vacuo. R-7a was obtained as a white solid (179 mg, 74%
yield). [a]20D = +40.0 (c = 0.5, CHCl3). All characterization data are in
agreement with that previously reported for S-7a.
General synthesis for insertion of the amino group in 1 position
S-12a or S,R-11c
A solution of (R)-(+)-3-chloro-1-phenyl-1-propanol or S,S-8c
(0.68 mmol) and triethylamine (190 mL, 1.36 mmol) in anhydrous
THF (5 mL) was cooled to 0 1C. Mesyl chloride (65 ml, 0.81 mmol)
in THF (1 mL) was added dropwise. The reaction was stirred for
2 h, filtrated and the solvent evaporated in vacuo. The mesylated
intermediate was used without any other purification step. The
compound was dissolved in dry DMF (5 mL) and NaN3 (65 mg,
1 mmol) was added. After stirring for 12 h at room temperature,
water (2 mL) was added and the solution was extracted with diethyl
ether (3  10 mL). The collected organic layers were washed with
an aqueous solution of NaHCO3, dried on Na2SO4, filtered and
evaporated to give the azido compound. In a stainless steel
autoclave (20 mL), equipped with temperature control and a
magnetic stirrer, purged five times with hydrogen, a solution of
the azido intermediate (0.67 mmol) in methanol with 1% of
Pd/C was transferred. The autoclave was pressurised at 20 atm
and kept under stirring at room temperature for four hours.
The mixture was then filtered on Celite and the solvent was
evaporated in vacuo to give the product.
Intermediate (1-azido-3-chloropropyl)benzene. (130 mg, 97%
yield). [a]20D = 123.8 (c = 0.5, CHCl3); 1H NMR (300 MHz, CDCl3):
d = 1.99–2.45 (m, 2H, –CH2–), 3.35–3.54 (m, 1H, –CHH–), 3.56–3.82
(m, 1H, –CHH–), 4.75 (dd, J = 8.4, 6.0 Hz, 1H, –CH–), 6.99–7.81 (m,
5H, arom); 13C NMR (75 MHz, CDCl3): d = 138.80, 129.24, 128.86,
127.15, 63.33, 41.57, 39.16. ppm; IR n = 3032, 2964, 2919, 2098,
1678, 1454, 1244, 760, 700 cm1; MS (ESI) of C9H10ClN3 m/z 196.7
([M + H]+).
(S)-3-Chloro-1-phenylpropan-1-amine S-12a. Yellow pale oil
(100 mg, 89% yield). [a]20D = +5.4 (c = 1.0, CH3OH);
1H NMR
(300 MHz, CDCl3): d = 2.12 (dd, J = 13.5, 7.0, 3.1 Hz, 2H, –CH2–),
3.01 (br, 2H, NH2), 3.35–3.48 (m, 1H, –CHH–), 3.52–3.65 (m, 1H,
–CHH–), 4.15 (t, J = 7.0 Hz, 1H, –CH–), 7.21–7.39 (m, 5H, arom)
ppm; 13C NMR (75 MHz, CD3OD): d = 143.80, 128.64, 127.82,
127.49, 126.78, 126.48, 126.24, 57.51, 53.38, 41.56, 41.15, 30.01,
9.77 ppm; IR n = 3352, 3270, 2933, 1602, 1453, 1348, 1072 cm1;
MS (ESI) of C9H12ClN m/z 170 ([M + H]
+).
Intermediate 2-(trimethylsilyl)ethyl((S)-2-((R)-azido(phenyl)
methyl)butyl)carbamate. [a]20D = +51.8 (c = 1.2, CHCl3);
1H NMR (300 MHz, CDCl3): d = 0.07 (s, 9H, –C(CH3)3), 0.92
(t, J = 7.70 Hz, 3H, –CH3), 1.25–1.39 (m, 2H, –CH2–), 1.43–1.50
(m, 2H, –CH2–), 1.83–1.86 (m, 1H, –CH–), 3.08–3.14 (t, J = 6.23 Hz,
2H, –CH2–), 4.13 (t, J = 9.89 Hz, 2H, –CH2–), 4.54 (d, J = 6.6 Hz,
1H, –CH–), 7.28–7.40 (m, 5H, arom) ppm; 13C NMR (75 MHz,
CDCl3): d = 156.98, 138.29, 129.03, 128.72, 128.48, 128.25,
127.44, 126.65, 77.89, 77.26, 76.62, 68.22, 63.25, 45.93, 41.33,
20.67, 17.98, 11.36, 1.25 ppm; IR n = 3339, 2956, 2100, 1704,
1524, 1250, 1176, 860, 838 cm1; MS (ESI) of C17H28N4O2Si m/z
374.3 ([M + Na]+).
2-(Trimethylsilyl)ethyl ((S)-2-((R)-amino(phenyl) methyl) butyl)-
carbamate S,R-11c. Colourless oil (76 mg, 35% total yield for three
steps) [a]20D = +6.46 (c = 1.3, CHCl3);
1H NMR (300 MHz, CDCl3):
d = 0.08 (s, 9H, –C(CH3)3), 0.95 (t, J = 8.03 Hz, 3H, –CH3), 1.15–1.42
(m, 4H, 2 –CH2–), 1.63–1.74 (m, 1H, –CH–), 2.85 (br, 2H, NH2),
3.08–3.21 (m, 2H, –CH2–), 4.09–4.13 (m, 3H, –CH2– + –CH–), 5.85
(br, 1H, NH), 7.21–7.38 (m, 5H, arom) ppm; 13C NMR (75 MHz,
CDCl3): d = 157.19, 143.25, 128.60, 128.25, 127.41, 127.03, 126.65,
126.17, 62.99, 57.91, 45.98, 41.94, 20.10, 17.99, 11.90, 1.25 ppm;
IR n = 3339, 2596, 1704, 1519, 1250, 860, 837 cm1; MS (ESI) of
C17H30N2O2Si m/z 323.2 ([M + H]
+).
General synthesis for sulphonamides in 1 position S-13a or S,R-12c
To a solution of S-12a or S,R-11c (0.53 mmol) in fresh-distilled
dichloromethane, triethylamine (112 mL, 0.79 mmol) was added.
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The reaction mixture was then cooled to 4 1C and stirred for
half an hour. A solution of tosyl chloride (126 mg, 0.66 mmol)
in dichloromethane was then dropped into the former solution
and stirred overnight allowing the reaction mixture to reach
room temperature. The reaction was monitored by TLC using
EtOAc/hexane 1 : 1 as an eluent.
(S)-N-(3-Chloro-1-phenylpropyl)-4-methylbenzenesulfonamide S-13a
The product was obtained as a white solid by slow diﬀusion of
hexane into the chloroform solution. (80 mg, 50% yield). [a]20D =
6.5 (c = 0.25, CHCl3); 1H NMR (300 MHz, CDCl3): d = 1.92–2.57
(m, 2H, –CH2–), 2.35 (s, 3H, –CH3), 3.19–3.27 (m, 1H, –CHH–),
3.32–3.51 (m, 1H, –CHH–), 4.52 (q, J = 7.4 Hz, 1H, –CH–),
5.55 (d, J = 7.6 Hz, 1H, NH), 7.00–7.16 (m, 7H, arom), 7.57
(d, J = 8.2 Hz, 2H, arom) ppm; 13C NMR (75 MHz, CDCl3):
d = 143.39, 139.81, 137.62, 129.95, 129.47, 128.88, 128.56,
127.96, 127.30, 126.79, 126.36, 55.98, 41.31, 40.16, 21.64 ppm;
IR n = 3436, 3265, 2965, 1600, 1458, 1325, 1161 cm1; elemental
analysis for C16H18ClNO2S: C, 59.34; H, 5.60; N, 4.33; found:
C, 58.98; H, 5.52; N, 4.21; MS (ESI) of C16H18ClNO2S m/z 346.3
([M + Na]+).
2-(Trimethylsilyl)ethyl ((S)-2-((R)-((4-methylphenyl)sulfon-
amido)(phenyl)methyl) butyl)carbamate S,R-12c:. Colourless
oil (100 mg, 40% yield). [a]20D = +20.4 (c = 0.9, CHCl3);
1H NMR (300 MHz, CDCl3): d = 0.05 (s, 9H, –C(CH3)3), 0.88 (t,
J = 8.06 Hz, 3H, –CH3), 0.96 (t, J = 8.06 Hz, 2H, –CH2–), 1.34–1.48
(m, 2H, –CH2–),1.81–1.93 (m, 1H, –CH–), 2.30 (s, 3H, –CH3),
3.18–3.24 (m, 2H, –CH2–), 4.18 (t, J = 6.78 Hz, 2H, –CH2–), 4.49–
4.56 (m, 1H, –CH–), 5.29 (br, 1H, NH), 5.49–5.53 (br, 1H, NH),
6.89–6.98 (m, 2H, arom), 7.04–7.14 (m, 5H, arom), 7.53 (d, J =
8.43, 2H, arom) ppm; 13C NMR (75 MHz, CDCl3): d = 157.13,
143.34, 139.22, 137.52, 129.49, 128.44, 127.17, 126.56, 63.26,
58.20, 47.04, 41.22, 29.90, 21.63, 18.00, 11.82, 1.23 ppm; IR n =
3382, 2597, 1694, 1532, 1251, 1160, 860, 838, 702 cm1; MS
(ESI) of C24H36N2O4SSi m/z 477.3 ([M + H]
+).
Synthesis of (S)-N-(3-azido-1-phenylpropyl)-4-methylbenzenesulfon-
amide S-14a
Compound 13a (40 mg, 0.124 mmol) was dissolved in dry
DMSO (5 mL) and NaN3 (80 mg, 1.24 mmol) was added. After
24 h at 100 1C, the solution was cooled to room temperature,
water (2 mL) was added and the mixture was extracted with
diethyl ether (3  5 mL). The collected organic layers were
washed with an aqueous solution of NaHCO3, dried on Na2SO4,
filtered and evaporated to give the product S-14a as a white
solid (40 mg, 97% yield). [a]20D = 14.3 (c = 0.4, CHCl3); 1H NMR
(300 MHz, CDCl3): d = 1.8–2.10 (m, 2H, –CH2–), 2.57 (s, 3H,
–CH3), 3.01–3.33 (m, 2H, –CH2–), 4.31 (dd, J = 8.1, 14.8 Hz, 1H,
–CH–), 6.65 (d, J = 8.2 Hz, 1H, NH), 6.98–7.16 (m, 7H, arom),
7.46 (d, J = 7.8, 2H, arom) ppm; 13C NMR (75 MHz, CDCl3): d =
143.43, 140.02, 137.72, 129.60, 129.45, 128.90, 128.57, 127.95,
127.28, 126.77, 126.56, 126.29, 56.12, 48.28, 36.59, 21.59 ppm;
IR n = 3232, 2963, 2091, 1599, 1455, 1323, 1156, 1088 cm1;
elemental analysis for C16H18N4O2S: C, 58.16; H, 5.49; N, 16.96;
found: C, 58.26; H, 5.51; N, 17.08; MS (ESI) of C16H18N4O2S m/z
353.3 ([M + Na]+).
Synthesis of (S)-N-(3-amino-1-phenylpropyl)-4-methylbenzenesulfon-
amide S-2
In a stainless steel autoclave (20 mL) equipped with temperature
control and a magnetic stirrer, purged five times with hydrogen, a
solution of 14a (40 mg, 0.121 mmol) in methanol with 1% of Pd/C
was transferred. The autoclave was pressurised at 20 atm and kept
under stirring at room temperature for four hours. The mixture
was then filtered on Celite and the solvent was evaporated
in vacuo to give the product S-2 as a yellow pale oil (35 mg,
95% yield). [a]20D = +5.4 (c = 1.5, CH3OH);
1H NMR (300 MHz,
CDCl3): d = 1.85–2.05 (m, 2H, –CH2–), 2.30 (s, 3H, –CH3),
2.77–2.9 (m, 2H, –CH2–), 4.46 (t, J = 6.5 Hz, 1H, –CH–),
6.97–7.16 (m, 7H, arom), 7.46 (d, J = 7.8 Hz, 2H, arom) ppm;
13C NMR (75 MHz, CDCl3): d = 142.82, 141.22, 138.12, 129.89,
129.36, 128.45, 127.21, 126.77, 126.56, 57.69, 38.89, 38.47,
21.57 ppm; IR n = 3352, 3270, 2933, 2103, 1652, 1453, 1328,
1152, 1091, 953, 817 cm1; MS (ESI) of C16H20N2O2S m/z 305.4
([M + H]+).
Synthesis of N-((1R,2S)-2-(aminomethyl)-1-phenylbutyl)-4-methyl-
benzenesulfonamide R,S-4
The synthesis proceeded as reported in the literature.37 The
product was recovered as colourless oil (58 mg, 87% yield).
[a]20D = +6.5 (c = 1.3, CHCl3);
1H NMR (300 MHz, CD3OD):
d = 0.86 (t, J = 7.33 Hz, 3H, –CH3), 1.37–1.43 (m, 2H, –CH2–),
2.25 (s, 3H, –CH3), 2.46 (d, J = 6.97 Hz, 1H, –CH–), 3.73–3.82
(m, 2H, –CH2–), 4.50 (d, J = 5.50 Hz, 1H, –CH–), 7.01–7.10
(m, 5H, arom), 7.43–7.51 (m, 4H, arom) ppm; 13C NMR (75 MHz,
CD3OD): d = 143.16, 138.47, 138.03, 129.02, 128.21, 127.12, 126.84,
126.76, 65.67, 58.19, 44.69, 20.10, 19.71, 10.32 ppm; IR n = 3252,
3063, 2968, 2353, 1661, 1598, 1455, 1325, 1159, 1091, 969, 814
cm1; MS (ESI) of C18H24N2O2S m/z 333.4 ([M + H]
+).
Typical procedure for asymmetric transfer hydrogenation
(ATH). A 10 mL Schlenk tube was loaded with [RuCl2( p-cymene)]2
(1 mmol), the diamine ligand (2.2 mmol) and charged with
distilled toluene (3 mL). The solution was refluxed at 110 1C for
3 h. The solvent was removed in vacuo. To a solution of the keto-
substrate (0.5 mmol) in water (2 mL), [Ru( p-cymene)(diamine)Cl]
(0.0025 mmol) in 20 mL DMSO and HCOONa as a hydrogen donor
(5 mmol, 10 eq.) were added. The reaction mixture was stirred at
40 1C for 48 h and extracted with ethyl acetate (2  5 mL). The
combined organic layers were dried with Na2SO4 and analysed
by HPLC.
Analytical HPLC conditions: Chiralcel OD-H, eluent:
hexane : ethanol = 95 : 5, flow = 0.8 mL min1, l = 216 nm:
1-Phenylethan-1-ol: rt: substrate 4.8 min, (R) = 5.4 min,
(S) = 6.0 min.
1-(o-Tolyl)ethan-1-ol: rt: substrate 6.3 min, (R) = 8.4 min,
(S) = 9.0 min.
1-(3-Methoxyphenyl)ethan-1-ol: rt: substrate 7.5 min, (R) =
12.6 min, (S) = 15.8 min.
1-(4-(Trifluoromethyl)phenyl)ethan-1-ol: rt: substrate 6.3 min,
(S) = 8.1 min, (R) = 8.4 min.
1-Phenylpropan-1-ol: rt: substrate 7.1 min, (R) = 9.9 min,
(S) = 10.9 min.
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Ethyl 4-hydroxy-4-phenylbutanoate: rt: substrate 12.8 min,
(R) = 13.9 min, (S) = 14.6 min.
Ethyl 3-hydroxy-3-phenylpropanoate: rt: substrate 7.7 min,
(S) = 11.6 min, (R) = 14.6 min.
1,2,3,4-Tetrahydronaphthalen-1-ol: rt: substrate 7.1 min,
(S) = 8.7 min, (R) = 9.1 min.
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